Prot #NU 16H06: A phase l clinical trial evaluating the combination of volasertib (Bl-6727) with vincristine sulfate liposomal injections (VSLI) in adult patients with relapsed/refractory acute lymphoblastic leukemia

Project: Research project

Project Details

StatusFinished
Effective start/end date8/24/16 → 8/24/20

Funding

  • National Comprehensive Cancer Network (Prot #NU 16H06 // Prot #NU 16H06)
  • Boehringer Ingelheim Pharmaceuticals, Inc. (Prot #NU 16H06 // Prot #NU 16H06)